THE USE OF RADIOACTIVE CHROMIUM 51 AS AN ERYTHROCYTE TAGGING AGENT FOR THE DETERMINATION OF RED CELL SURVIVAL IN VIVO

^{Robert Dawson Evans Memorial Laboratory, Massachusetts Memorial Hospitals, Boston, Mass.}

^{Department of Medicine, Boston University School of Medicine, Boston, Mass.}

Part of this work was performed while a Public Health Service Research Fellow of the National Cancer Institute.

This work was supported in part by a contract between the Atomic Energy Commission and the Massachusetts Memorial Hospitals, and funds from the American Cancer Society of Massachusetts, Inc., Boston Blood Grouping Laboratory.

Presented in part before the Committee on Blood and Related Problems, National Research Council, Washington, D. C., September 17, 1952, and the American Federation for Clinical Research, Eastern Section, Boston, Massachusetts, April 16, 1953.

Find articles by Ebaugh, F. in: PubMed | Google Scholar

^{Robert Dawson Evans Memorial Laboratory, Massachusetts Memorial Hospitals, Boston, Mass.}

^{Department of Medicine, Boston University School of Medicine, Boston, Mass.}

Part of this work was performed while a Public Health Service Research Fellow of the National Cancer Institute.

This work was supported in part by a contract between the Atomic Energy Commission and the Massachusetts Memorial Hospitals, and funds from the American Cancer Society of Massachusetts, Inc., Boston Blood Grouping Laboratory.

Presented in part before the Committee on Blood and Related Problems, National Research Council, Washington, D. C., September 17, 1952, and the American Federation for Clinical Research, Eastern Section, Boston, Massachusetts, April 16, 1953.

Find articles by Emerson, C. in: PubMed | Google Scholar

^{Robert Dawson Evans Memorial Laboratory, Massachusetts Memorial Hospitals, Boston, Mass.}

^{Department of Medicine, Boston University School of Medicine, Boston, Mass.}

Part of this work was performed while a Public Health Service Research Fellow of the National Cancer Institute.

This work was supported in part by a contract between the Atomic Energy Commission and the Massachusetts Memorial Hospitals, and funds from the American Cancer Society of Massachusetts, Inc., Boston Blood Grouping Laboratory.

Presented in part before the Committee on Blood and Related Problems, National Research Council, Washington, D. C., September 17, 1952, and the American Federation for Clinical Research, Eastern Section, Boston, Massachusetts, April 16, 1953.

Find articles by Ross, J. in: PubMed | Google Scholar

^{Robert Dawson Evans Memorial Laboratory, Massachusetts Memorial Hospitals, Boston, Mass.}

^{Department of Medicine, Boston University School of Medicine, Boston, Mass.}

Part of this work was performed while a Public Health Service Research Fellow of the National Cancer Institute.

This work was supported in part by a contract between the Atomic Energy Commission and the Massachusetts Memorial Hospitals, and funds from the American Cancer Society of Massachusetts, Inc., Boston Blood Grouping Laboratory.

Presented in part before the Committee on Blood and Related Problems, National Research Council, Washington, D. C., September 17, 1952, and the American Federation for Clinical Research, Eastern Section, Boston, Massachusetts, April 16, 1953.

Find articles by Aloia, R. in: PubMed | Google Scholar

^{Robert Dawson Evans Memorial Laboratory, Massachusetts Memorial Hospitals, Boston, Mass.}

^{Department of Medicine, Boston University School of Medicine, Boston, Mass.}

Part of this work was performed while a Public Health Service Research Fellow of the National Cancer Institute.

This work was supported in part by a contract between the Atomic Energy Commission and the Massachusetts Memorial Hospitals, and funds from the American Cancer Society of Massachusetts, Inc., Boston Blood Grouping Laboratory.

Presented in part before the Committee on Blood and Related Problems, National Research Council, Washington, D. C., September 17, 1952, and the American Federation for Clinical Research, Eastern Section, Boston, Massachusetts, April 16, 1953.

Find articles by Halperin, P. in: PubMed | Google Scholar

^{Robert Dawson Evans Memorial Laboratory, Massachusetts Memorial Hospitals, Boston, Mass.}

^{Department of Medicine, Boston University School of Medicine, Boston, Mass.}

Part of this work was performed while a Public Health Service Research Fellow of the National Cancer Institute.

This work was supported in part by a contract between the Atomic Energy Commission and the Massachusetts Memorial Hospitals, and funds from the American Cancer Society of Massachusetts, Inc., Boston Blood Grouping Laboratory.

Presented in part before the Committee on Blood and Related Problems, National Research Council, Washington, D. C., September 17, 1952, and the American Federation for Clinical Research, Eastern Section, Boston, Massachusetts, April 16, 1953.

Find articles by Richards, H. in: PubMed | Google Scholar